Maravai shares surge 10.43% premarket after Q4 positive EBITDA, $65M cost savings, and raised 2026 guidance.

Maravai surged 10.43% in premarket trading following its Q4 2025 earnings report, which highlighted a return to positive adjusted EBITDA of $536,000 (vs. -$1.1M in Q4 2024), driven by cost savings, improved revenue mix, and demand for key products. The company also outlined $65M+ annualized expense savings from restructuring, voluntary $50M debt repayment, and a 2026 outlook projecting 8–13% revenue growth and $18–20M adjusted EBITDA. Despite a $63M GAAP net loss, the results exceeded Zacks estimates for EPS and revenue, with management emphasizing operational improvements and customer engagement. The stock’s sharp rise reflects optimism over its turnaround strategy and stronger-than-expected EBITDA performance.